Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL396298 (Elacridar, LY-335979, LY335979) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ABCG2/ATP-binding cassette sub-family G member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
ChEMBL | Inhibition of BCRP expressed in MDCK cells by pheophorbide A assay | B | 6.37 | pIC50 | 430 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 180-183 [PMID:19932960] |
ChEMBL | Inhibition of ABCG2 expressed in HEK293 cells assessed as mitoxantrone-mediated efflux by flow cytometry | B | 6.39 | pIC50 | 410 | nM | IC50 | Bioorg Med Chem (2007) 15: 2892-2897 [PMID:17317193] |
ChEMBL | Inhibition of BCRP expressed in MCF7 MX cells by Hoechst 33342 staining | B | 6.4 | pIC50 | 400 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 180-183 [PMID:19932960] |
ChEMBL | Inhibition of sulfasalazine-stimulated BCRP ATP ase activity (unknown origin) | B | 6.6 | pIC50 | 252.2 | nM | IC50 | J Med Chem (2021) 64: 3677-3693 [PMID:33729781] |
ChEMBL | Inhibition of ABCG2 overexpressed in human MCF7/Topo cells by flow cytometric-based mitoxantrone efflux assay | B | 6.6 | pIC50 | 250 | nM | IC50 | J Med Chem (2009) 52: 1190-1197 [PMID:19170519] |
GtoPdb | - | - | 6.71 | pIC50 | 193 | nM | IC50 | ACS Med Chem Lett (2013) 4: 393-6 [PMID:24900683] |
ChEMBL | Inhibition of ABCG2 expressed in human MCF7/Topo cells by Hoechst microplate assay | B | 6.9 | pIC50 | 127 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3654-3657 [PMID:21570282] |
ChEMBL | Inhibition of ABCG2 in human MCF7/Topo cells after 2 hrs by Hoechst 33342 microplate assay | B | 6.9 | pIC50 | 127 | nM | IC50 | ACS Med Chem Lett (2013) 4: 393-396 [PMID:24900683] |
GtoPdb | - | - | 6.9 | pIC50 | 127 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3654-7 [PMID:21570282] |
ABCC1/Multidrug resistance-associated protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3004] [GtoPdb: 779] [UniProtKB: P33527] | ||||||||
ChEMBL | Inhibition of NEM-GS-stimulated MRP1 ATPase activity (unknown origin) in presence of GSH | B | 5.38 | pIC50 | >4128 | nM | IC50 | J Med Chem (2021) 64: 3677-3693 [PMID:33729781] |
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
GtoPdb | Inhibition of digoxin transport in Caco-2 cells | - | 7.4 | pKi | 40 | nM | Ki | Pharm Res (2003) 20: 161-8 [PMID:12636153] |
ChEMBL | Inhibition of ABCB1-mediated [3H]vinblastine transportation in human Caco-2 cells | B | 5.7 | pIC50 | 2000 | nM | IC50 | J Med Chem (2008) 51: 7602-7613 [PMID:19053888] |
ChEMBL | Inhibition of ABCB1 overexpressed in human KBv1 cells by flow cytometric-based calcein-AM efflux assay | B | 6.71 | pIC50 | 193 | nM | IC50 | J Med Chem (2009) 52: 1190-1197 [PMID:19170519] |
ChEMBL | Inhibition of ABCB1 expressed in Kb-V1 cells after 10 mins by calcein-AM assay | B | 6.71 | pIC50 | 193 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3654-3657 [PMID:21570282] |
ChEMBL | Inhibition of ABCB1 in human KBV1 cells after 10 mins by Calcein-AM microplate assay | B | 6.71 | pIC50 | 193 | nM | IC50 | ACS Med Chem Lett (2013) 4: 393-396 [PMID:24900683] |
ChEMBL | Inhibition of P-glycoprotein-mediated daunorubicin efflux from human CCRF-CEM/VCR1000 cells after 240 secs by FACS flow cytometric analysis | B | 7.14 | pIC50 | 72.44 | nM | IC50 | J Med Chem (2012) 55: 3261-3273 [PMID:22452412] |
ChEMBL | Inhibition of paclitaxel stimulated- P-gp ATPase activity (unknown origin) | B | 8.31 | pIC50 | 4.9 | nM | IC50 | J Med Chem (2021) 64: 3677-3693 [PMID:33729781] |
ChEMBL | Inhibition of Pgp measured as inhibition of [3H]vinblastine basolateral to apical transport in Caco-2 cells | F | 5.7 | pEC50 | 2000 | nM | EC50 | J Med Chem (2006) 49: 6607-6613 [PMID:17064079] |
ChEMBL | Inhibition of human P-glycoprotein mediated [3H]vinblastine transport in human Caco-2 cells | B | 5.7 | pEC50 | 2000 | nM | EC50 | J Med Chem (2008) 51: 1415-1422 [PMID:18257545] |
ChEMBL | Inhibition of human Pgp mediated [3H]vinblastine transport in human Caco-2 cells | B | 5.7 | pEC50 | 2000 | nM | EC50 | Bioorg Med Chem (2008) 16: 362-373 [PMID:17936633] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]